Formulation: A crystalline solid
Pricing updated 2018-10-21. Prices are subject to change without notice.
1-(3-Trifluoromethylphenyl)piperazine (TFMPP) is an entactogenic drug which selectively promotes the release of serotonin.1 When used in combination with 1-benzylpiperazine, TFMPP increases both serotonin and dopamine, mirroring the effects of 3,4-methylenedioxymethamphetamine.1 Drug-drug synergism may induce seizures.1 TFMPP has been identified in party pills and powders.2,3 Its metabolism in rats has been described.4 This product is intended for forensic applications.
Warning - this product is not for human or veterinary use.
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GC-MS spectra of many of Cayman's emerging forensic drug standards
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Baumann, M.H., Clark, R.D., Budzynski, A.G., et al. N-
2. Hill, S.L., and Thomas, S.H. Clinical toxicology of newer recreational drugs. Clin.Toxicol.(Phila) 49(8), 705-719 (2011).
3. Arbo, M.D., Bastos, M.L., and Carmo, H.F. Piperazine compounds as drugs of abuse. Drug Alcohol Depend. 122(3), 174-185 (2012).
4. Staack, R.F., and Maurer, H.H. Metabolism of designer drugs of abuse. Curr.Drug Metab. 6(3), 259-274 (2005).